secwatch / observer
8-K filed February 2, 2023, 6:59 PM ET ticker MTSI CIK 0001493594
earnings confidence high sentiment neutral materiality 0.70

MACOM Q1 revenue $180.1M (+12.8% YoY); adjusted EPS $0.81; Q2 guidance below Q1

MACOM Technology Solutions Holdings, Inc.

2023-Q1 EPS reported $0.41 revenue$180,104,000

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

MACOM Technology Solutions Holdings, Inc. reported fiscal first quarter ended December 30, 2022 results: revenue $180.1 million, net income $29.5 million, EPS $0.41 per diluted share. Guidance initiated.

Period
fiscal first quarter ended December 30, 2022
Revenue
$180.1 million
Net income
$29.5 million
EPS
$0.41 per diluted share
Guidance
initiated
Result
reported results
Exact text from the filing
Revenue was $180.1 million, an increase of 12.8%, compared to $159.6 million in the previous year fiscal first quarter and an increase of 1.1% compared to $178.1 million in the prior fiscal quarter; • Gross margin was 61.3%, compared to 59.0% in the previous year fiscal first quarter and 60.9% in the prior fiscal quarter; • Operating income was $38.6 million, or 21.4% of revenue, compared to operating income of $27.1 million, or 17.0% of revenue, in the previous year fiscal first quarter and operating income of $37.0 million, or 20.8% of revenue, in the prior fiscal quarter; and • Net income was $29.5 million, or $0.41 per diluted share, compared to net income of $138.8 million, or $1.95 per diluted share, in the previous year fiscal first quarter and net income of $239.3 million, or $3.36 per diluted share, in the prior fiscal quarter.
View on SEC.gov

Browse all earnings releases →

MACOM Technology Solutions Holdings, Inc. filing history →

Source: SEC EDGAR
accession 0001493594-23-000032
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.